Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06134271
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-18
First Post:
2023-10-29
Brief Title:
Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer
Sponsor:
Jianbin Bi
Organization:
First Hospital of China Medical University
Organization Data
Organization:
First Hospital of China Medical University
Class:
OTHER
Study ID:
FirstHCMU-JBi-RASTOM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jianbin Bi
Lead Sponsor Class:
OTHER
Responsible Party:
Jianbin Bi
Responsible Party Title:
Director of Urology Department the First Hospital of China Medical University
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
First Hospital of China Medical University
Old Name:
None
Old Organization:
None